在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

POLE Antibody

  • 中文名稱:
    POLE兔多克隆抗體
  • 貨號:
    CSB-PA824463
  • 規格:
    ¥2024
  • 圖片:
    • Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using POLE1 antibody.
  • 其他:

產品詳情

  • 產品名稱:
    Rabbit anti-Homo sapiens (Human) POLE Polyclonal antibody
  • Uniprot No.:
  • 基因名:
  • 宿主:
    Rabbit
  • 反應種屬:
    Human,Mouse
  • 免疫原:
    Synthesized peptide derived from internal of Human POLE1.
  • 免疫原種屬:
    Homo sapiens (Human)
  • 克隆類型:
    Polyclonal
  • 純化方式:
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA,IHC
  • 推薦稀釋比:
    Application Recommended Dilution
    IHC 1:50-1:100
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Catalytic component of the DNA polymerase epsilon complex. Participates in chromosomal DNA replication. Required during synthesis of the leading DNA strands at the replication fork, binds at/or near replication origins and moves along DNA with the replication fork. Has 3'-5' proofreading exonuclease activity that corrects errors arising during DNA replication. Involved in DNA synthesis during DNA repair. Along with DNA polymerase POLD1 and DNA polymerase POLK, has a role in excision repair (NER) synthesis following UV irradiation.
  • 基因功能參考文獻:
    1. Data suggest that DNA polymerase epsilon catalytic subunit (POLE) mutation does not serve as a relevant biomarker and should not be tested on a regular basis in pancreatic ductal adenocarcinoma (PDAC). PMID: 30194485
    2. These findings support a role for E2 beyond E1 recruitment in human papillomavirus 11 DNA replication, and further implicate cellular pol epsilon in viral DNA replication. PMID: 29895728
    3. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability PMID: 29659608
    4. Mutation in DNA Polymerase II gene is associated with MMR deficiency in cancer. PMID: 28512192
    5. Meta-analysis found that POLE proofreading domain mutations identify a subset of immunogenic colorectal cancers with excellent prognosis. PMID: 28404093
    6. This is the first study to functionally analyze a POLE genetic variant outside the exonuclease domain and widens the spectrum of genetic changes in this DNA polymerase that could lead to colorectal cancer predisposition. PMID: 28423643
    7. Mutational analysis of hypermutation-related POLE gene in acute leukemias and lymphomas. PMID: 28034776
    8. The basic biochemical mechanisms leading to a unique phenotype in POLE deficiency as well as challenges faced with interpreting the genomic profiling of tumors in this important subset of patients and the potential clinical implications will be discussed here PMID: 28465371
    9. Data show that the POLE mutation leading to hypermutation can accelerate cancer development. PMID: 27612425
    10. The POLE mutations have in selecting for mutations of the beta2 microglobulin (B2M) gene involved in antigen presentation. PMID: 29320758
    11. POLE exonuclease domain mutations are prognostic markers associated with excellent outcomes for endometrial carcinoma patients. PMID: 26763250
    12. Case Reports: POLE heterozygous mutations were found in two colorectal adenocarcinomas. PMID: 29072370
    13. POLE mutations in tumors of women with grade 3 EEC are associated with a lower risk of recurrence and death, although not statistically significant because of high variability in these estimates. PMID: 26937754
    14. We present the case of a patient with a left frontal glioblastoma with primitive neuroectodermal tumor features and hypermutated genotype in the setting of a POLE germline alteration PMID: 27683556
    15. Frameshift mutation in POLE gene is associated with mismatch repair-deficiency and Lynch syndrome. PMID: 28218421
    16. POLE-mutated undifferentiated and dedifferentiated endometrial carcinomas were more frequently stage I tumors than similar carcinomas lacking exonuclease domain mutations (7/9; 78% vs. 3/12; 25%; P=0.023) and patients had significantly better outcome (disease-specific survival) than those without POLE exonuclease domain mutations (P=0.02) PMID: 28498284
    17. In colorectal cancers, mutations in the FBXW7 gene were more common in the younger cohort (27.5% vs 9.7%; P = .0022) as were mutations in the proofreading domain of polymerase epsilon catalytic subunit (POLE) (9.8% vs 1%; P = .0048). PMID: 27244218
    18. POLE ultra-mutated endometrial-carcinomas are heavily infiltrated with CD4+/CD8+ TIL, overexpress PD-1 immune-check-point, and have a better prognosis when compared to other molecular subtypes of endometrial-carcinomas patients. POLE-mutated tumor-cell lines are resistant to platinum-chemotherapy in-vitro suggesting that the better prognosis of POLE-patients is not secondary to a higher sensitivity to ch PMID: 27894751
    19. Tumors with POLE EDMs had the most favorable prognosis, and those with p53 abn the worst prognosis, and separation of the 2 middle survival curves (p53 wt and MMR-D) was observed PMID: 28061006
    20. POLE1 is phosphorylated at serine-1940 after DNA damage and interacts with the iron-sulfur complex chaperones CIAO1 and MMS19. PMID: 27235625
    21. POLE-mutated endometrial carcinomas are typically of high grade, with prominent lymphocytic infiltration, but they are not sufficiently distinctive to allow accurate diagnosis based on routine haematoxylin and eosin staining PMID: 26416160
    22. Study identified a high penetrant duplication in the regulatory region of GREM1, predisposing to colorectal cancer (CRC) in a family with attenuated/ atypical polyposis. A POLE variant was also identified in a patient with early onset CRC. PMID: 26493165
    23. POLE mutations are associated with cutaneous melanoma. PMID: 26251183
    24. Identified a genomically, histologically, and clinically distinct subgroup of high-grade gliomas that harbored somatic POLE mutations and carried an improved prognosis. PMID: 25740784
    25. Missense point mutations in POLE gene is associated with Ovarian Endometrioid Carcinoma. PMID: 26166557
    26. A novel c.1373A>T (p.Tyr458Phe)POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine. PMID: 25860647
    27. POLE proofreading-mutant endometrial cancers are characterized by a robust intratumoral T-cell response, which correlates with, and may be caused by an enrichment of antigenic neopeptides PMID: 25878334
    28. Results show that that mutated POLE 1 are associated with high neoantigen loads and may be excellent candidates for PD-1-targeted immunotherapies. PMID: 26181000
    29. the recognition of ultramutated endometrial carcinomas with POLE exonuclease domain mutation is important given their favorable outcome PMID: 25394778
    30. The kinetic parameters of the truncated catalytic subunit and holoenzyme of human DNA polymerase varepsilon are compared. PMID: 25684708
    31. POLE ultra-mutated-tumors are significantly more immunogenic when compared to POLE (-) tumors, in particular to the helper arm of the immune system. PMID: 25931171
    32. Data indicate that the polymerase (DNA directed), epsilon protein (POLE) mutation c.1270C>G;p.Leu424Val was detected in 1.5% (4/266) of all patients, 4% (3/77) of all familial cases and 7% (2/30) of familial polyposis cases. PMID: 25529843
    33. Data indicate that exonuclease domain of DNA polymerase epsilon (POLE-exo*) mutants generate a unique pattern of replication errors. PMID: 25228659
    34. Somatic POLE exonuclease domain mutations are common in endometrioid endometrial cancer, are observed with equal frequency in tumors with microsatellite stability and those with microsatellite instability, and are not associated with survival. PMID: 25224212
    35. Hearing ability was strongly associated with DNA methylation levels in the promoter regions of several genes, including TCF25, FGFR1, and POLE. PMID: 25184702
    36. The 3'-->5' exonuclease activity of hPol further enhances polymerization fidelity by an unprecedented 3.5 x 10(2) to 1.2 x 10(4)-fold. PMID: 25414327
    37. POLE mutations have been found in other tumor types, though at lower frequency, suggesting roles in tumorigenesis more broadly in different tissue types. [Review] PMID: 24861832
    38. A new amino-acid substitution in POLE was identified resulting in a predisposition to a broad spectrum of tumours in addition to colorectal cancers. PMID: 24788313
    39. POLE exonuclease domain mutations occur in a subset of grade 3 endometrioid carcinomas and are associated with good clinical outcome. PMID: 24844595
    40. Mutant Pol epsilon causes replication errors in vivo. In colorectal patients, the single allele mutations are microsatellite stable with a large increase in base pair substitutions, consistent with requirement of additional factors for tumor development. PMID: 24051051
    41. Heterozygosity for the variant allele caused a strong mutator effect comparable with that of complete mismatch repair deficiency, providing an explanation for why loss of heterozygosity is not required for the development of Polepsilon-mutant human tumors. PMID: 24525744
    42. The POLE1 p.S297F mutation was frequent in Chinese ovarian endometrioid carcinoma. PMID: 24472300
    43. To catalyze leading-strand synthesis in vivo, Polepsilon likely interacts with its three smaller subunits and additional replication factors in order to assemble a replication complex and significantly enhance its polymerization processivity. PMID: 24020356
    44. observed impairment in proliferation and G1- to S-phase progression in patients' T lymphocytes. Polepsilon1 depletion also impaired G1- to S-phase progression in B lymphocytes, chondrocytes, and osteoblasts. PMID: 23230001
    45. Pol epsilon is a likely source of ribonucleotides in human genomic DNA. PMID: 23093410
    46. Data show that using a 200-nt primed circular DNA substrate, the combined action of DNA polymerase epsilon and the Cdc45/Mcm2-7/GINS (CMG complex) leads to the formation of products >10 kb in length. PMID: 22474384
    47. Mutation in the POLE gene that encodes p261 catalytic subunit of pol epsilon is the first found in human cells. PMID: 21157497
    48. SNPs associated with prognosis of lung cancer was mapped to POLE. PMID: 17855454
    49. An AATT deletion in the 55 kDa small subunit DNA sequence of DNA polymerase epsilon is associated with breast cancer PMID: 19129559

    顯示更多

    收起更多

  • 相關疾病:
    Colorectal cancer 12 (CRCS12); Facial dysmorphism, immunodeficiency, livedo, and short stature (FILS)
  • 亞細胞定位:
    Nucleus.
  • 蛋白家族:
    DNA polymerase type-B family
  • 數據庫鏈接:

    HGNC: 9177

    OMIM: 174762

    KEGG: hsa:5426

    STRING: 9606.ENSP00000322570

    UniGene: Hs.524871



主站蜘蛛池模板: 在线精品视频一区二区| 国产品无码一区二区三区在线| 日韩激情无码免费毛片| 国产亚洲精品第一综合不卡| 手机在线亚洲国产精品| 女人被男人躁得好爽免费视频| 一区二区三区无码被窝影院| 中国女人大白屁股ass| 亚洲aⅴ天堂av天堂无码app| 久久人人爽爽人人爽人人片av| 国产剧情av麻豆香蕉精品| 国产黑色丝袜在线观看下| 色情无码www视频无码区澳门| 午夜无码人妻av大片色欲| 国产精品人妻一码二码尿失禁| 高潮喷吹一区二区在线观看| 亚洲精品久久久久中文字幕一福利| 日韩欧美亚洲国产精品字幕久久久| 中国大陆高清aⅴ毛片| 中文字幕人妻熟女av| 天堂资源在线官网| 夜夜高潮夜夜爽夜夜爱| 国产精品欧美一区二区三区| 国产在线观看免费视频软件| 蜜臀avwww国产天堂| 草草影院发布页| 亚洲欧美日韩中文字幕在线一区| 国产ae86亚洲福利入口| 久久天天躁狠狠躁夜夜96流白浆| 黄桃av无码免费一区二区三区| 午夜免费福利小电影| 亚洲中文字幕av不卡无码| 国产真实乱对白精彩久久| 国产精品成人99一区无码| 中文在线中文a| 国产熟妇人妻精品一区二区动漫| 中国美女毛茸茸撒尿| 国产精品-区区久久久狼| 国产人妻久久精品二区三区| 最近中文av字幕在线中文| 久久国产劲爆∧v内射-百度|